| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
1,430,000,000 |
| Market
Cap: |
104.63(B) |
| Last
Volume: |
8,786,292 |
Avg
Vol: |
8,469,733 |
| 52
Week Range: |
$48.64 - $73.26 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 500 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 297 |
| Guru Rank Value : 4.1 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
86,763 |
367,796 |
891,893 |
1,852,495 |
| Total Sell Value |
$5,815,387 |
$21,391,604 |
$49,075,093 |
$90,475,166 |
| Total People Sold |
6 |
8 |
11 |
13 |
| Total Sell Transactions |
9 |
19 |
36 |
69 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Mirviss Jeffrey B. |
SVP&Pres, Periph InterventOffi |
• – – |
2013-01-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,648 |
|
- |
|
| Mirviss Jeffrey B. |
SVP&Pres, Periph InterventOffi |
• – – |
2013-01-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
56,541 |
|
- |
|
| Ballinger Kevin J. |
SVP & Pres, Interven CardioOff |
• – – |
2013-01-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
91,825 |
|
- |
|
| Prange Karen |
SVP&Pres, Uro & Womens HealthO |
• – – |
2013-01-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,000 |
|
- |
|
| Carruthers Wendy |
SVP, Human ResourcesOfficer |
• – – |
2012-12-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
32,505 |
|
- |
|
| Nicholas Nicholas J Jr |
Director |
• • – |
2012-11-13 |
4 |
B |
$5.20 |
$105,596 |
I/I |
20,000 |
225,000 |
2.1 |
- |
|
| Nicholas Nicholas J Jr |
Director |
• • – |
2012-11-09 |
4 |
B |
$5.15 |
$129,305 |
I/I |
25,000 |
205,000 |
2.1 |
- |
|
| Mahoney Michael F |
President & CEO |
• • – |
2012-11-01 |
4 |
D |
$5.24 |
$567,544 |
D/D |
(108,310) |
255,359 |
|
- |
|
| Mahoney Michael F |
President & CEO |
• • – |
2012-11-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
341,669 |
363,669 |
|
- |
|
| Onuscheck John Michael |
SVP & President, EMEA |
• • – |
2012-10-30 |
4 |
D |
$5.17 |
$4,462 |
D/D |
(863) |
60,547 |
|
- |
|
| Onuscheck John Michael |
SVP & President, EMEA |
• • – |
2012-10-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,290 |
61,410 |
|
- |
|
| Nanavaty Maulik |
SVP & Pres, Neuromodulation |
• • – |
2012-10-30 |
4 |
D |
$5.17 |
$8,686 |
D/D |
(1,680) |
65,272 |
|
- |
|
| Nanavaty Maulik |
SVP & Pres, Neuromodulation |
• • – |
2012-10-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,580 |
66,952 |
|
- |
|
| Spriggs Otha T. Iii |
SVP, Human Resources |
• • – |
2012-09-07 |
4 |
D |
$5.63 |
$12,848 |
D/D |
(2,282) |
12,738 |
|
- |
|
| Spriggs Otha T. Iii |
SVP, Human Resources |
• • – |
2012-09-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,198 |
15,020 |
|
- |
|
| Nicholas Peter M |
Director |
• • – |
2012-08-27 |
4 |
AS |
$0.00 |
$0 |
I/I |
(82,995) |
834,361 |
|
- |
|
| Nicholas Peter M |
Director |
• • – |
2012-08-27 |
4 |
AS |
$0.00 |
$0 |
D/D |
(236,690) |
3,414,739 |
|
- |
|
| Abele John E |
Director Emeritus |
• • – |
2012-08-27 |
4 |
AS |
$0.00 |
$0 |
D/D |
(480,272) |
92,983 |
|
- |
|
| Nicholas Peter M |
Director |
• • – |
2012-08-20 |
4 |
AS |
$0.00 |
$0 |
I/I |
(84,425) |
899,298 |
|
- |
|
| Nicholas Peter M |
Director |
• • – |
2012-08-20 |
4 |
AS |
$0.00 |
$0 |
D/D |
(237,240) |
3,651,429 |
|
- |
|
| Abele John E |
Director Emeritus |
• • – |
2012-08-17 |
4 |
AS |
$0.00 |
$0 |
D/D |
(480,551) |
573,255 |
|
- |
|
| Abele John E |
Director Emeritus |
• • – |
2012-08-13 |
4 |
AS |
$0.00 |
$0 |
D/D |
(488,177) |
1,053,806 |
|
- |
|
| Nicholas Peter M |
Director |
• • – |
2012-08-13 |
4 |
AS |
$0.00 |
$0 |
I/I |
(84,425) |
965,123 |
|
- |
|
| Nicholas Peter M |
Director |
• • – |
2012-08-09 |
4 |
AS |
$0.00 |
$0 |
D/D |
(237,240) |
3,888,669 |
|
- |
|
| Abele John E |
Director Emeritus |
• • – |
2012-08-06 |
4 |
AS |
$0.00 |
$0 |
D/D |
(490,000) |
1,541,983 |
|
- |
|
1831 Records found
|
|
Page 16 of 74 |
|
|
0.09 (0.12%) 
